companiesSEC EDGAR
Prelude Therapeutics Inc
SEC EDGAR published this disclosure on 2026-08-11. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001193125-26-343475
cik1678660
company namePrelude Therapeutics Inc
form10-Q